Specifically, they found that 66% of 80 individuals with widespread ovarian cancer had serum hK6 in excess of 15 μg l−1 while only two out of 217 individuals with a wide array of other malignancies with high tumour burden had the same. The gene discussed is KLK6; the disease is ovarian carcinoma.